The Asia Pacific immunohistochemistry market size was estimated at USD 491.60 million in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2030. Increase in the prevalence of chronic conditions, such as cancer, certain infectious diseases, autoimm... Read More »
January 2024The U.S. in vitro diagnostics market size was estimated at USD 29.86 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 3.70% from 2024 to 2030. The market growth is declining due to a decrease in demand for COVID-19 tests during the forecast period. Howe... Read More »
December 2023The global prostate cancer diagnostics market size was estimated at USD 8.56 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.4% from 2024 to 2030. Increasing prevalence of prostate cancer is a major factor contributing to the market growth. According ... Read More »
December 2023The global point-of-care molecular diagnostics market size was estimated at USD 8.17 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 2.5% from 2024 to 2030. Increasing prevalence of chronic and infectious diseases and genetic disorders, such as Alzheime... Read More »
December 2023The global blood culture test market size was estimated at USD 5.92 billion in 2023 and is expected to growat a compound annual growth rate (CAGR) of 12.3% from 2024 to 2030. Increasing approval of novel products by regulatory bodies for bloodstream infection (BSI) diagnosis and increasi... Read More »
December 2023The global laboratory proficiency testing market size was estimated at USD 1.36 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.6% from 2024 to 2030. Increasing focus on water testing, legalization of medical cannabis, growing number of cannabis testi... Read More »
December 2023The global direct-to-consumer genetic testing market size was valued at USD 1.93 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 24.4% from 2024 to 2030. Direct-to-consumer (DTC) genetic testing has become increasingly popular in recent years, as advanc... Read More »
December 2023The global non invasive prenatal testing market size was valued at USD 4.21 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 10.06% from 2024 to 2030. The increasing demand for non invasive prenatal testing (NIPT), rising collaborations & licensing a... Read More »
December 2023The global neurological biomarkers market size was valued at USD 8.05 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 12.89% from 2024 to 2030. Technological advancements, a rising prevalence of neurological disorders such as Parkinson's disease, Alzhei... Read More »
December 2023The global in-vitro diagnostics enzymes market size was valued at USD 2.39 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.9% from 2023 to 2030. Enzymes are adopted in the diagnosis of various metabolic disorders owing to their remarkable catalytic... Read More »
December 2023The global in situ hybridization market size was estimated at USD 1.60 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 7.2% from 2024 to 2030. Growing demand for molecular diagnostic tools is anticipated to boost the adoption of in situ hybridization (... Read More »
December 2023The Canada nuclear medicine market size was valued at USD 414.31 million in 2023 and is estimated to grow at a compound annual growth rate (CAGR) of 15.16% from 2024 to 2030. The growth of Canada’s nuclear medicine market is attributed to the increasing demand for early & accur... Read More »
December 2023The global urinalysis market size was valued at USD 2.14 billion in 2022 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.7% from 2023 to 2030. The market is witnessing growth due to factors including the rising incidence of diseases such as Urinary Tract Infecti... Read More »
December 2023The global central lab market size was valued at USD 3.28 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.44% from 2024 to 2030. The growth can be attributed to increasing investment in R&D and increased focus of sponsors & investigators on r... Read More »
December 2023The global liquid biopsy market size was estimated at USD 10.42 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 11.60% from 2024 to 2030. The market for liquid biopsy is witnessing growth due to factors such as the growing prevalence of cancer, technol... Read More »
December 2023The global breast cancer core needle biopsy market was valued at USD 776.97 million in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.9% from 2023 to 2030. The market is rapidly expanding, driven by factors such as the increasing prevalence of breast malignanci... Read More »
December 2023The Europe in vitro diagnostics market size was valued at USD 28.98 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 0.7 % from 2023 to 2030.The growing base of the geriatric population in European countries, the increasing prevalence of chronic disea... Read More »
December 2023The global qPCR instruments market size was valued at USD 1.0 billion in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 7.0% from 2023 to 2030. The growing prevalence of diseases, technological advancements, and increasing demand for qPCR ins... Read More »
December 2023The global cancer diagnostics market size was estimated at USD 107.45 billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 6.16% from 2024 to 2030. The growth of this industry is attributed to the growing prevalence of cancer, technological advancements in d... Read More »
November 2023The U.S. influenza diagnostics market size was valued at USD 179.9 million in 2022 and is anticipated to grow at a compound annual growth rate (CAGR) of 5.9% from 2023 to 2030. The recurring seasonal outbreaks of influenza act as a key driving force for the market. Increased awareness am... Read More »
November 2023